000 | 01917 a2200529 4500 | ||
---|---|---|---|
005 | 20250513144148.0 | ||
264 | 0 | _c19980626 | |
008 | 199806s 0 0 eng d | ||
022 | _a0024-3205 | ||
024 | 7 |
_a10.1016/s0024-3205(98)00197-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBryant, C E | |
245 | 0 | 0 |
_aVascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells. _h[electronic resource] |
260 |
_bLife sciences _c1998 |
||
300 |
_a2195-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCyclooxygenase 1 |
650 | 0 | 4 | _aCyclooxygenase 2 |
650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aDinoprostone _xmetabolism |
650 | 0 | 4 |
_aEndothelial Growth Factors _xpharmacology |
650 | 0 | 4 |
_aEndothelium, Vascular _xcytology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
650 | 0 | 4 |
_aLymphokines _xpharmacology |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNitric Oxide Synthase Type III |
650 | 0 | 4 |
_aNitrobenzenes _xpharmacology |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 | _aUp-Regulation |
650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
650 | 0 | 4 | _aVascular Endothelial Growth Factors |
700 | 1 | _aAppleton, I | |
700 | 1 | _aMitchell, J A | |
773 | 0 |
_tLife sciences _gvol. 62 _gno. 24 _gp. 2195-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0024-3205(98)00197-0 _zAvailable from publisher's website |
999 |
_c9593463 _d9593463 |